-
Alvarez FJD, He S, Perilla JR, Jang S, Schulten K, Engelman AN, Scheres SHW, Zhang P (2017) CryoEM structure of MxB reveals a novel oligomerization interface critical for HIV restriction. Sci Adv 3:e1701264–e1701264
doi: 10.1126/sciadv.1701264
-
Betancor G, Dicks MDJ, Jimenez-Guardeno JM, Ali NH, Apolonia L, Malim MH (2019) The GTPase domain of MX2 interacts with the HIV-1 capsid, enabling its short isoform to moderate antiviral restriction. Cell Rep 29(1923–1933):e1923
-
Buffone C, Schulte B, Opp S, Diaz-Griffero F (2015) Contribution of MxB oligomerization to HIV-1 capsid binding and restriction. J Virol 89:3285–3294
doi: 10.1128/JVI.03730-14
-
Busnadiego I, Kane M, Rihn SJ, Preugschas HF, Hughes J, Blanco-Melo D, Strouvelle VP, Zang TM, Willett BJ, Boutell C, Bieniasz PD, Wilson SJ (2014) Host and viral determinants of Mx2 antiretroviral activity. J Virol 88:7738–7752
doi: 10.1128/JVI.00214-14
-
Butler SL, Hansen MS, Bushman FD (2001) A quantitative assay for HIV DNA integration in vivo. Nat Med 7:631–634
doi: 10.1038/87979
-
Chen Y, Zhang L, Graf L, Yu B, Liu Y, Kochs G, Zhao Y, Gao S (2017) Conformational dynamics of dynamin-like MxA revealed by single-molecule FRET. Nat Commun 8:15744
doi: 10.1038/ncomms15744
-
Crameri M, Bauer M, Caduff N, Walker R, Steiner F, Franzoso FD, Gujer C, Boucke K, Kucera T, Zbinden A, Munz C, Fraefel C, Greber UF, Pavlovic J (2018) MxB is an interferon-induced restriction factor of human herpesviruses. Nat Commun 9:1980
doi: 10.1038/s41467-018-04379-2
-
Di Nunzio F, Fricke T, Miccio A, Valle-Casuso JC, Perez P, Souque P, Rizzi E, Severgnini M, Mavilio F, Charneau P, Diaz-Griffero F (2013) Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication. Virology 440:8–18
doi: 10.1016/j.virol.2013.02.008
-
Dick A, Graf L, Olal D, von der Malsburg A, Gao S, Kochs G, Daumke O (2015) Role of nucleotide binding and GTPase domain dimerization in dynamin-like myxovirus resistance protein A for GTPase activation and antiviral activity. J Biol Chem 290:12779–12792
doi: 10.1074/jbc.M115.650325
-
Dicks MDJ, Betancor G, Jimenez-Guardeno JM, Pessel-Vivares L, Apolonia L, Goujon C, Malim MH (2018) Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction. PLoS Pathog 14:e1007408
doi: 10.1371/journal.ppat.1007408
-
Ebina H, Aoki J, Hatta S, Yoshida T, Koyanagi Y (2004) Role of Nup98 in nuclear entry of human immunodeficiency virus type 1 cDNA. Microbes Infect 6:715–724
doi: 10.1016/j.micinf.2004.04.002
-
Fribourgh JL, Nguyen HC, Matreyek KA, Alvarez FJD, Summers BJ, Dewdney TG, Aiken C, Zhang P, Engelman A, Xiong Y (2014) Structural insight into HIV-1 restriction by MxB. Cell Host Microbe 16:627–638
doi: 10.1016/j.chom.2014.09.021
-
Fricke T, White TE, Schulte B, de Souza Aranha Vieira DA, Dharan A, Campbell EM, Brandariz-Nunez A, Diaz-Griffero F (2014) MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1. Retrovirology 11:68
doi: 10.1186/s12977-014-0068-x
-
Goujon C, Moncorge O, Bauby H, Doyle T, Ward CC, Schaller T, Hue S, Barclay WS, Schulz R, Malim MH (2013) Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 502:559–562
doi: 10.1038/nature12542
-
Goujon C, Greenbury RA, Papaioannou S, Doyle T, Malim MH (2015) A triple-arginine motif in the amino-terminal domain and oligomerization are required for HIV-1 inhibition by human MX2. J Virol 89:4676–4680
doi: 10.1128/JVI.00169-15
-
Haller O, Staeheli P, Schwemmle M, Kochs G (2015) Mx GTPases: dynamin-like antiviral machines of innate immunity. Trends Microbiol 23:154–163
doi: 10.1016/j.tim.2014.12.003
-
Kane M, Yadav SS, Bitzegeio J, Kutluay SB, Zang T, Wilson SJ, Schoggins JW, Rice CM, Yamashita M, Hatziioannou T, Bieniasz PD (2013) MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 502:563–566
doi: 10.1038/nature12653
-
King MC, Raposo G, Lemmon MA (2004) Inhibition of nuclear import and cell-cycle progression by mutated forms of the dynamin-like GTPase MxB. Proc Natl Acad Sci USA 101:8957–8962
doi: 10.1073/pnas.0403167101
-
Kitagawa Y, Kameoka M, Shoji-Kawata S, Iwabu Y, Mizuta H, Tokunaga K, Fujino M, Natori Y, Yura Y, Ikuta K (2008) Inhibitory function of adapter-related protein complex 2 alpha 1 subunit in the process of nuclear translocation of human immunodeficiency virus type 1 genome. Virology 373:171–180
doi: 10.1016/j.virol.2007.11.033
-
Kong J, Xu B, Wei W, Wang X, Xie W, Yu XF (2014) Characterization of the amino-terminal domain of Mx2/MxB-dependent interaction with the HIV-1 capsid. Protein Cell 5:954–957
doi: 10.1007/s13238-014-0113-5
-
Kong J, Ma M, He S, Qin X (2016) Mx oligomer: a novel capsid pattern sensor? Future Microbiol 11:1047–1055
doi: 10.2217/fmb-2016-0004
-
Li N, Luo F, Chen Q, Zhu N, Wang H, Xie L, Xiong H, Yue M, Zhang Y, Feng Y, Hou W (2019) IFN-lambdas inhibit Hantaan virus infection through the JAK-STAT pathway and expression of Mx2 protein. Genes Immun 20:234–244
doi: 10.1038/s41435-018-0028-x
-
Liu Z, Pan Q, Ding S, Qian J, Xu F, Zhou J, Cen S, Guo F, Liang C (2013) The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe 14:398–410
doi: 10.1016/j.chom.2013.08.015
-
Matreyek KA, Wang W, Serrao E, Singh PK, Levin HL, Engelman A (2014) Host and viral determinants for MxB restriction of HIV-1 infection. Retrovirology 11:90
doi: 10.1186/s12977-014-0090-z
-
Meier K, Jaguva Vasudevan AA, Zhang Z, Bähr A, Kochs G, Häussinger D, Münk C (2018) Equine MX2 is a restriction factor of equine infectious anemia virus (EIAV). Virology 523:52–63
doi: 10.1016/j.virol.2018.07.024
-
Nigg PE, Pavlovic J (2015) Oligomerization and GTP-binding requirements of MxA for viral target recognition and antiviral activity against influenza A virus. J Biol Chem 290:29893–29906
doi: 10.1074/jbc.M115.681494
-
Schilling M, Bulli L, Weigang S, Graf L, Naumann S, Patzina C, Wagner V, Bauersfeld L, Goujon C, Hengel H, Halenius A, Ruzsics Z, Schaller T, Kochs G (2018) Human MxB protein is a pan-herpesvirus restriction factor. J Virol 92:e01056-18
-
Staeheli P, Haller O (2018) Human MX2/MxB: a potent interferon-induced postentry inhibitor of herpesviruses and HIV-1. J Virol 92:e00709–e00718
-
Verhelst J, Hulpiau P, Saelens X (2013) Mx proteins: antiviral gatekeepers that restrain the uninvited. Microbiol Mol Biol Rev 77:551–566
doi: 10.1128/MMBR.00024-13
-
Wang YX, Niklasch M, Liu T, Wang Y, Shi B, Yuan W, Baumert TF, Yuan Z, Tong S, Nassal M, Wen YM (2020) Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication. J Hepatol 75:865–876
-
Yi DR, An N, Liu ZL, Xu FW, Raniga K, Li QJ, Zhou R, Wang J, Zhang YX, Zhou JM, Zhang LL, An J, Qin CF, Guo F, Li XY, Liang C, Cen S (2019) Human MxB inhibits the replication of hepatitis C virus. J Virol 93:e01285-18
-
Zhang R, Mehla R, Chauhan A (2010) Perturbation of host nuclear membrane component RanBP2 impairs the nuclear import of human immunodeficiency virus -1 preintegration complex (DNA). PLoS One 5:e15620
doi: 10.1371/journal.pone.0015620